Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 182

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 4
Chunk 182
---
aries: Alpha Tau Medical, Inc., which is incorporated in the United States, Alpha Tau Medical Canada, which is incorporated under
the laws of Quebec, and Alpha Tau Medical KK, which is incorporated under the laws of Japan.

  Property, Plants and Equipment  
 ──────────────────────────────────

Our principal facilities are
located in Jerusalem, Israel and consist of approximately 2,600 square meters (approximately 28,000 square feet) of leased office space
and a manufacturing facility. These facilities currently accommodate our principal executive offices, research and development, account
management, marketing, design, business development, finance, and other administrative activities. Of our total 130 employees as of December
31, 2024, 112 are located in Israel. The lease for these facilities expires in May 2035.

In addition, we operate a manufacturing facility
in Lawrence, MA, USA, which began producing Thorium-228 generators at the start of 2021. We also have a long-term leasehold on a plot
of land of approximately 6,660 square meters (1.65 acres) in the Har Hotzvim Industrial Park in Jerusalem, and are currently constructing
a commercial-scale manufacturing facility in a leased standalone building of over 14,000 rentable square feet in Hudson, NH, USA. We believe
that our facilities are adequate to meet our needs for the immediate future, and that, should it be needed, suitable additional space
will be available to accommodate any such expansion of our operations. We have also constructed our own radioactive pre-clinical laboratory
at our headquarters in Jerusalem, Israel, which is conducting pre-clinical studies, to explore potential combination therapies with Alpha
DaRT

Item 4A. Unresolved Staff Comments